Maxime Lemarchand is currently a Partner at Redstart and 50 Partners, and is actively involved as an investor in numerous companies such as gyfti, Comet Meetings, and Emprunte Mon Toutou. As a co-founder and CEO of illico Fresco and Prescription Lab, Maxime has established a strong entrepreneurial background, having co-founded various startups including SURPRIZEMI. Holding a Master of Science in International Business from ESCEM and Université de Sherbrooke, Maxime continues to contribute to the business landscape through strategic investments and advisory roles.
This person is not in the org chart
This person is not in any teams
This person is not in any offices